David G. Orloff, MD
Executive Director, Medpace Regulatory Affairs

Dr. Orloff is an endocrinologist and has 11 years of regulatory experience, with major foci in diabetes, obesity, and lipid metabolism. He is the immediate past director of the Division of Metabolism and Endocrinology Products within the Center for Drug Evaluation and Research (CDER) of the FDA.

Contact Information

Medpace, Inc.
5375 Medpace Way
Cincinnati, Ohio 45227
USA

Tel: +1.513.579.9911
Fax: +1.513.579.0444
E-mail: info@medpace.com